EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,000 | -25.0% | 70 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $4,000 | 0.0% | 70 | +7.7% | 0.00% | 0.0% |
Q2 2021 | $4,000 | -20.0% | 65 | +14.0% | 0.00% | 0.0% |
Q1 2021 | $5,000 | +66.7% | 57 | +83.9% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 31 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $3,000 | -25.0% | 31 | -38.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | -75.0% | 50 | -82.5% | 0.00% | -66.7% |
Q1 2020 | $16,000 | +6.7% | 285 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $15,000 | 0.0% | 285 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $15,000 | +7.1% | 285 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $14,000 | 0.0% | 285 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $14,000 | -44.0% | 285 | -32.9% | 0.00% | -60.0% |
Q4 2018 | $25,000 | -65.3% | 425 | -61.2% | 0.01% | -58.3% |
Q3 2018 | $72,000 | -71.0% | 1,095 | -77.7% | 0.01% | -73.3% |
Q2 2018 | $248,000 | -3.9% | 4,905 | 0.0% | 0.04% | -4.3% |
Q1 2018 | $258,000 | +13.2% | 4,905 | 0.0% | 0.05% | +14.6% |
Q4 2017 | $228,000 | +15.2% | 4,905 | 0.0% | 0.04% | +10.8% |
Q3 2017 | $198,000 | +17.9% | 4,905 | -1.0% | 0.04% | +8.8% |
Q2 2017 | $168,000 | +16.7% | 4,955 | 0.0% | 0.03% | +17.2% |
Q1 2017 | $144,000 | -11.7% | 4,955 | 0.0% | 0.03% | -19.4% |
Q4 2016 | $163,000 | +5.8% | 4,955 | +1.6% | 0.04% | +9.1% |
Q3 2016 | $154,000 | +12.4% | 4,875 | 0.0% | 0.03% | +10.0% |
Q2 2016 | $137,000 | -20.3% | 4,875 | +3.0% | 0.03% | -23.1% |
Q1 2016 | $172,000 | 0.0% | 4,735 | +9.9% | 0.04% | 0.0% |
Q4 2015 | $172,000 | +50.9% | 4,310 | +8.2% | 0.04% | +39.3% |
Q3 2015 | $114,000 | -13.0% | 3,984 | 0.0% | 0.03% | -3.4% |
Q2 2015 | $131,000 | +19.1% | 3,984 | +3.8% | 0.03% | +16.0% |
Q1 2015 | $110,000 | +4.8% | 3,839 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $105,000 | +28.0% | 3,839 | 0.0% | 0.02% | +31.6% |
Q3 2014 | $82,000 | -4.7% | 3,839 | 0.0% | 0.02% | 0.0% |
Q2 2014 | $86,000 | +21.1% | 3,839 | +37.2% | 0.02% | +11.8% |
Q1 2014 | $71,000 | – | 2,799 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |